The global pain therapeutic injectables Industry size is expected to develop at a CAGR of 4.5% between 2023 and 2033, with estimations for 2023 being about US$ 20.0 billion. By the end of 2033, the market is expected to reach US$ 30.9 billion. The Pain Therapeutic Injectables Market refer to medications that are administered through …
Monthly Archives: January 2024
USA Medical Coding Industry is set to offer a lucrative investment avenue, with a projected value of US$ 2.3 Billion by 2033 | FMI
As per the analysis by Future Market Insights, the USA medical coding industry size is valued at US$ 1.0 Billion in 2023 and is projected to exhibit a CAGR growth of close to 8.4% over the forecast period, with an estimated valuation of US$ 2.3 Billion by 2033. Recent innovations in the field of medical …
Global 3D Printing Photopolymers Industry to achieve a value of US$ 5.0 Billion by 2033, with a CAGR of 18.3% | FMI
The global 3D printing photopolymers industry size is anticipated to reach US$ 935.0 million in 2023. Between 2023 and 2033, the market is forecast to increase at a CAGR of 18.3%, and by the end of 2033, it is anticipated to reach US$ 5.0 billion. 3D printing, also known as additive manufacturing, has emerged as …
Boutique Hotel Market Unique Travel to US$ 115.80 Billion with a 6.7% CAGR by 2032 | FMI
The boutique hotel market is expected to grow at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2032, from an anticipated US$ 93.37 billion in 2022 to US$ 115.80 billion by that time. The boutique hotel market is a dynamic sector characterized by unique, intimate, and stylish accommodations. Unlike conventional hotels, boutique establishments focus on personalized experiences, reflecting the local …
Global USA Electronic Health Records (EHR) Industry is anticipated to soar to US$ 15.3 Billion by 2033 in the US Healthcare Sector, according to FMI’s analysis
The USA electronic health records (EHR) industry size is anticipated to reach a value of US$ 9.1 billion in 2023 and grow at a CAGR of 5.3% to reach US$ 15.3 billion by 2033. In 2022, the USA market will be led by EHR Software in the solution sector, with a market share of roughly …
Global VR Stroke Rehabilitation Industry is on an upward trajectory, anticipated to attain a value of US$ 376.0 billion by 2033, influenced by the increasing prevalence of strokes | FMI
The global VR stroke rehabilitation industry size is expected to reach US$ 376.0 billion by 2033, growing at a CAGR of 9.2% over the forecast period, according to a recent report by Future Market Insights. The growth of the VR stroke rehabilitation market is attributed to a number of factors, including the rising prevalence of …
Global Nephroblastoma Treatment Industry is projected to be US$ 5.44 Billion by 2033 | FMI
According to Future Market Insights, the global nephroblastoma therapeutics industry size is projected to rise at a steady growth valued at US$ 2.12 billion in 2023, with a 9.88% CAGR until 2033, being valued at US$ 5.44 billion. The important factors that are compelling the growth of the revenue of the nephroblastoma therapeutics market are …
Global Nerve Entrapment Syndrome Therapeutics Industry is expected to grow at a 6.81% CAGR and reach US$ 8.04 Billion by 2033 as per FMI’s study
According to Future Market Insights, the global nerve entrapment syndrome therapeutics industry size is projected to rise at a steady growth valued at US$ 4.16 billion in 2023, with a 6.81% CAGR until 2033, being valued at US$ 8.04 billion. As per FMI, around 60–70% of people suffering from diabetes are projected to have diabetic …
Global Nasopharyngeal Carcinoma Treatment Industry will achieve a US$ 2.1 Billion valuation by 2033, primarily driven by Advanced Healthcare Solutions, FMI
During the forecast period 2023 to 2033, the global nasopharyngeal carcinoma treatment industry size is expected to grow at a value of 5.9% CAGR, according to Future Market Insights. The industry is valued at US$ 1.18 Billion in 2023. By the year 2033, the global market for Nasopharyngeal carcinoma treatment is expected to rise up …
Global Non-Sterile Liquids/Suspensions Industry is forecasted to experience a 6.5% CAGR expansion by 2033, with Personalized Medicine identified as the primary driver, per FMI
The global non-sterile liquids/suspensions industry size is anticipated to reach US$ 2.8 billion in 2023 and US$ 5.2 billion by the end of 2033. Between 2023 and 2033, the market is anticipated to develop at a 6.5% CAGR. According to a recent analysis by Future Market Insights, the oral dosage form would dominate the global …